Server Sadik, Sabet Soheil, Yaghouti Kourosh, Namal Esat, Inan Nagihan, Tokat Yaman
Department of Radiology, Istanbul Bilim University, Sisli Florence Nightingale Hospital, Istanbul, Turkey.
Department of Radiology, Istanbul Bilim University, Sisli Florence Nightingale Hospital, Istanbul, Turkey.
Transplant Proc. 2019 Sep;51(7):2403-2407. doi: 10.1016/j.transproceed.2019.01.178. Epub 2019 Aug 8.
The purpose of this study was to determine the utility of some imaging findings in predicting microvascular invasion (MVI) and hepatocellular carcinoma (HCC) recurrence risk after liver transplantation.
This retrospective study included 123 patients with histopathologically proven HCC at explant. All HCCs were classified as MVI positive (group I) or negative (group II) based on histopathological findings. In each group, multifocality, largest tumor size, bulging (tumor causing liver capsule expansion), beak sign (the acute angle between the tumor and liver parenchyma), and diffusion restriction on diffusion weighted images (DWI) were evaluated. These findings were compared between the groups by Student's t test. The relation between the parameters and MVI was analyzed by using the Spearman's correlation test.
Of the total patients, 30.1% had MVI (group I) and 69.9% (group II) did not have MVI. Presence of beak sign (P ≤ .005), bulging sign (P = .002), and diffusion restriction (P = .045) were significantly more frequent in group I than group II. The beak sign, bulging sign, and diffusion restriction were correlated with presence of MVI. Largest tumor size and multifocality were higher in group I than group II, but the differences were not statistically significant.
Radiologists and transplant surgeons should be aware of some clue imaging findings, especially beak and bulging signs because these findings may predict the presence of MVI in HCC. These patients might benefit from histologic confirmation of the tumor characteristics through biopsy and subsequent bridging treatment options before liver transplantation to reduce the risk of recurrence.
本研究旨在确定某些影像学表现对预测肝移植后微血管侵犯(MVI)及肝细胞癌(HCC)复发风险的作用。
本回顾性研究纳入了123例肝移植时经组织病理学证实为HCC的患者。根据组织病理学结果,将所有HCC分为MVI阳性组(I组)和MVI阴性组(II组)。对每组患者的多灶性、最大肿瘤大小、隆起(肿瘤导致肝包膜扩张)、喙征(肿瘤与肝实质之间的锐角)以及扩散加权成像(DWI)上的扩散受限情况进行评估。采用Student's t检验对两组之间的这些表现进行比较。使用Spearman相关性检验分析各参数与MVI之间的关系。
在所有患者中,30.1%有MVI(I组),69.9%无MVI(II组)。I组中喙征(P≤0.005)、隆起征(P = 0.002)和扩散受限(P = 0.045)的出现频率显著高于II组。喙征、隆起征和扩散受限与MVI的存在相关。I组的最大肿瘤大小和多灶性高于II组,但差异无统计学意义。
放射科医生和移植外科医生应注意一些提示性的影像学表现,尤其是喙征和隆起征,因为这些表现可能提示HCC中MVI的存在。这些患者可能受益于在肝移植前通过活检对肿瘤特征进行组织学确认以及后续的桥接治疗方案,以降低复发风险。